Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200383817> ?p ?o ?g. }
- W4200383817 endingPage "S768" @default.
- W4200383817 startingPage "S767" @default.
- W4200383817 abstract "Abstract Background The National Academy of Medicine has identified stigma surrounding substance use disorders (SUDs) and infectious diseases (ID) as a key barrier to integration of opioid use disorder (OUD) and ID services. Prior literature on stigmatizing language in OUD clinical care focuses on surveys and theoretical scenarios rather than real-world data. As part of a larger study of patients admitted for infectious complications of injection drug use (CHOICE), we sought to determine how inpatient physicians describe persons with OUD, as well as associations of this language with outcomes along the OUD continuum of care. Methods CHOICE is a retrospective review of adults hospitalized with an infectious complication of OUD and IDU at four academic medical centers. Included patients were hospitalized between 1/1/2018-12/31/2018, had ICD9/10 diagnosis codes consistent with OUD and acute bacterial/fungal infection, and chart review verification of active infection associated with OUD. Data was abstracted regarding demographics, inpatient interventions, transitions of care, and outcomes 1 year after admission. Potentially stigmatizing language was identified based on the discharge summary. “Abuse” and “misuse” were considered potentially stigmatizing; “use disorder” was considered best practice. Associations of language and outcomes were analyzed via logistic generalized estimating equations. Results A total of 287 subjects met inclusion criteria; 119 (42%) were female and the median age was 40 years (IQR: 32 – 52). The most common terms used to describe OUD were “abuse” (190, 66%) and “IVDU” (119, 42%). “Use disorder” was noted in only 72 (25%) charts. In a regression analysis, any mention of “use disorder” was associated with not leaving against medical advice (OR 2.48, 95% CI 1.24 – 4.95), a plan for ongoing OUD treatment (OR 5.17, 95% CI 2.05-13.0), and addiction-specific follow up (OR 2.94, 95% CI 2.34-3.68). Conclusion In this multicenter retrospective study, inpatient physicians commonly referred to patients with OUD using stigmatizing language. When NIH-preferred language was used this was associated with improved outcomes along the OUD continuum of care, possibly reflecting increased awareness of best practices for treating patients with OUD. Disclosures Ellen Eaton, MD , Gilead (Grant/Research Support) Ellen Eaton, MD , Gilead (Individual(s) Involved: Self): Research Grant or Support Greer A. Burkholder, MD, MSPH, Eli Lilly (Grant/Research Support) Sarah Kattakuzhy, MD, Gilead Sciences (Scientific Research Study Investigator, Research Grant or Support) Elana S. Rosenthal, MD, Gilead Sciences (Research Grant or Support)Merck (Research Grant or Support)" @default.
- W4200383817 created "2021-12-31" @default.
- W4200383817 creator A5003568343 @default.
- W4200383817 creator A5004633780 @default.
- W4200383817 creator A5007488565 @default.
- W4200383817 creator A5007922186 @default.
- W4200383817 creator A5008932800 @default.
- W4200383817 creator A5010019047 @default.
- W4200383817 creator A5017140354 @default.
- W4200383817 creator A5021580400 @default.
- W4200383817 creator A5032891625 @default.
- W4200383817 creator A5044441844 @default.
- W4200383817 creator A5051200499 @default.
- W4200383817 creator A5053849596 @default.
- W4200383817 creator A5066715059 @default.
- W4200383817 creator A5085516894 @default.
- W4200383817 creator A5089395699 @default.
- W4200383817 date "2021-11-01" @default.
- W4200383817 modified "2023-09-26" @default.
- W4200383817 title "1362. Adding Insult to Injury: Association of Stigmatizing Language and Suboptimal Outcomes in People Who Inject Drugs" @default.
- W4200383817 doi "https://doi.org/10.1093/ofid/ofab466.1554" @default.
- W4200383817 hasPublicationYear "2021" @default.
- W4200383817 type Work @default.
- W4200383817 citedByCount "0" @default.
- W4200383817 crossrefType "journal-article" @default.
- W4200383817 hasAuthorship W4200383817A5003568343 @default.
- W4200383817 hasAuthorship W4200383817A5004633780 @default.
- W4200383817 hasAuthorship W4200383817A5007488565 @default.
- W4200383817 hasAuthorship W4200383817A5007922186 @default.
- W4200383817 hasAuthorship W4200383817A5008932800 @default.
- W4200383817 hasAuthorship W4200383817A5010019047 @default.
- W4200383817 hasAuthorship W4200383817A5017140354 @default.
- W4200383817 hasAuthorship W4200383817A5021580400 @default.
- W4200383817 hasAuthorship W4200383817A5032891625 @default.
- W4200383817 hasAuthorship W4200383817A5044441844 @default.
- W4200383817 hasAuthorship W4200383817A5051200499 @default.
- W4200383817 hasAuthorship W4200383817A5053849596 @default.
- W4200383817 hasAuthorship W4200383817A5066715059 @default.
- W4200383817 hasAuthorship W4200383817A5085516894 @default.
- W4200383817 hasAuthorship W4200383817A5089395699 @default.
- W4200383817 hasBestOaLocation W42003838171 @default.
- W4200383817 hasConcept C118552586 @default.
- W4200383817 hasConcept C126322002 @default.
- W4200383817 hasConcept C144024400 @default.
- W4200383817 hasConcept C149923435 @default.
- W4200383817 hasConcept C151956035 @default.
- W4200383817 hasConcept C160735492 @default.
- W4200383817 hasConcept C162324750 @default.
- W4200383817 hasConcept C167135981 @default.
- W4200383817 hasConcept C168285401 @default.
- W4200383817 hasConcept C170493617 @default.
- W4200383817 hasConcept C194828623 @default.
- W4200383817 hasConcept C27415008 @default.
- W4200383817 hasConcept C2779418921 @default.
- W4200383817 hasConcept C2780084366 @default.
- W4200383817 hasConcept C2781063702 @default.
- W4200383817 hasConcept C2781385661 @default.
- W4200383817 hasConcept C40010229 @default.
- W4200383817 hasConcept C50522688 @default.
- W4200383817 hasConcept C512399662 @default.
- W4200383817 hasConcept C71924100 @default.
- W4200383817 hasConceptScore W4200383817C118552586 @default.
- W4200383817 hasConceptScore W4200383817C126322002 @default.
- W4200383817 hasConceptScore W4200383817C144024400 @default.
- W4200383817 hasConceptScore W4200383817C149923435 @default.
- W4200383817 hasConceptScore W4200383817C151956035 @default.
- W4200383817 hasConceptScore W4200383817C160735492 @default.
- W4200383817 hasConceptScore W4200383817C162324750 @default.
- W4200383817 hasConceptScore W4200383817C167135981 @default.
- W4200383817 hasConceptScore W4200383817C168285401 @default.
- W4200383817 hasConceptScore W4200383817C170493617 @default.
- W4200383817 hasConceptScore W4200383817C194828623 @default.
- W4200383817 hasConceptScore W4200383817C27415008 @default.
- W4200383817 hasConceptScore W4200383817C2779418921 @default.
- W4200383817 hasConceptScore W4200383817C2780084366 @default.
- W4200383817 hasConceptScore W4200383817C2781063702 @default.
- W4200383817 hasConceptScore W4200383817C2781385661 @default.
- W4200383817 hasConceptScore W4200383817C40010229 @default.
- W4200383817 hasConceptScore W4200383817C50522688 @default.
- W4200383817 hasConceptScore W4200383817C512399662 @default.
- W4200383817 hasConceptScore W4200383817C71924100 @default.
- W4200383817 hasIssue "Supplement_1" @default.
- W4200383817 hasLocation W42003838171 @default.
- W4200383817 hasOpenAccess W4200383817 @default.
- W4200383817 hasPrimaryLocation W42003838171 @default.
- W4200383817 hasRelatedWork W2152326527 @default.
- W4200383817 hasRelatedWork W2607029909 @default.
- W4200383817 hasRelatedWork W2777612558 @default.
- W4200383817 hasRelatedWork W2932411505 @default.
- W4200383817 hasRelatedWork W2945171425 @default.
- W4200383817 hasRelatedWork W3157198265 @default.
- W4200383817 hasRelatedWork W3197850556 @default.
- W4200383817 hasRelatedWork W3205671225 @default.
- W4200383817 hasRelatedWork W4304631779 @default.
- W4200383817 hasRelatedWork W4309765745 @default.
- W4200383817 hasVolume "8" @default.
- W4200383817 isParatext "false" @default.
- W4200383817 isRetracted "false" @default.